The type I interferon receptor mediates tyrosine phosphorylation of the CrkL adaptor protein

被引:85
作者
Ahmad, S
Alsayed, YM
Druker, BJ
Platanias, LC
机构
[1] UNIV ILLINOIS, HEMATOL ONCOL SECT, MBRB, CHICAGO, IL 60607 USA
[2] W SIDE VET ADM MED CTR, CHICAGO, IL 60607 USA
[3] OREGON HLTH SCI UNIV, DIV HEMATOL & MED ONCOL, PORTLAND, OR 97201 USA
关键词
D O I
10.1074/jbc.272.48.29991
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interferon (IFN) alpha induces rapid and transient tyrosine phosphorylation of the Src homology 2/Src homology 3 (SH2/SH3)-containing CrkL adaptor protein in a time-and dose-dependent manner. Such phosphorylation is most likely regulated by the Type I interferon receptor (IFNR)-associated Tyk-2 kinase, as suggested by the detection of Type I IFN-dependent tyrosine kinase activity in anti-CrkL immunoprecipitates and the IFN alpha-dependent association of CrkL with Tyk-2 in intact cells. Two other Type I IFNs, IFN beta and IFN omega, also induce tyrosine phosphorylation of CrkL, suggesting that the protein is involved in the signaling pathways of several different Type I IFNs. In the IFN alpha-sensitive U-266 and Daudi cell lines, CrkL interacts via its N terminus SH3 domain with the guanine exchange factor C3G that regulates activation of Rap-1, a small G-protein that exhibits tumor suppressor activity, Thus, tyrosine phosphorylation of CrkL links the functional Type I IFNR complex to the C3G-Rap-1 signaling cascade that mediates growth inhibitory responses.
引用
收藏
页码:29991 / 29994
页数:4
相关论文
共 49 条
  • [21] MUTANT U5A CELLS ARE COMPLEMENTED BY AN INTERFERON-ALPHA-BETA RECEPTOR SUBUNIT GENERATED BY ALTERNATIVE PROCESSING OF A NEW MEMBER OF A CYTOKINE RECEPTOR GENE-CLUSTER
    LUTFALLA, G
    HOLLAND, SJ
    CINATO, E
    MONNERON, D
    REBOUL, J
    ROGERS, NC
    SMITH, JM
    STARK, GR
    GARDINER, K
    MOGENSEN, KE
    KERR, IM
    UZE, G
    [J]. EMBO JOURNAL, 1995, 14 (20) : 5100 - 5108
  • [22] A NOVEL VIRAL ONCOGENE WITH STRUCTURAL SIMILARITY TO PHOSPHOLIPASE-C
    MAYER, BJ
    HAMAGUCHI, M
    HANAFUSA, H
    [J]. NATURE, 1988, 332 (6161) : 272 - 275
  • [23] Targeted disruption of the STAT1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway
    Meraz, MA
    White, JM
    Sheehan, KCF
    Bach, EA
    Rodig, SJ
    Dighe, AS
    Kaplan, DH
    Riley, JK
    Greenlund, AC
    Campbell, D
    CarverMoore, K
    DuBois, RN
    Clark, R
    Aguet, M
    Schreiber, RD
    [J]. CELL, 1996, 84 (03) : 431 - 442
  • [24] THE PROTEIN-TYROSINE KINASE JAK1 COMPLEMENTS DEFECTS IN INTERFERON-ALPHA/BETA AND INTERFERON-GAMMA SIGNAL-TRANSDUCTION
    MULLER, M
    BRISCOE, J
    LAXTON, C
    GUSCHIN, D
    ZIEMIECKI, A
    SILVENNOINEN, O
    HARPUR, AG
    BARBIERI, G
    WITTHUHN, BA
    SCHINDLER, C
    PELLEGRINI, S
    WILKS, AF
    IHLE, JN
    STARK, GR
    KERR, IM
    [J]. NATURE, 1993, 366 (6451) : 129 - 135
  • [25] NICHOLS GL, 1994, BLOOD, V84, P2912
  • [26] THE HUMAN INTERFERON-ALPHA/BETA RECEPTOR - CHARACTERIZATION AND MOLECULAR-CLONING
    NOVICK, D
    COHEN, B
    RUBINSTEIN, M
    [J]. CELL, 1994, 77 (03) : 391 - 400
  • [27] ODA T, 1994, J BIOL CHEM, V269, P22925
  • [28] A SPECIES OF HUMAN ALPHA-INTERFERON THAT LACKS THE ABILITY TO BOOST HUMAN NATURAL-KILLER ACTIVITY
    ORTALDO, JR
    HERBERMAN, RB
    HARVEY, C
    OSHEROFF, P
    PAN, YCE
    KELDER, B
    PESTKA, S
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (15): : 4926 - 4929
  • [29] Pestka S, 1997, Semin Oncol, V24, pS9
  • [30] INTERFERONS AND THEIR ACTIONS
    PESTKA, S
    LANGER, JA
    ZOON, KC
    SAMUEL, CE
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 1987, 56 : 727 - 777